Serum miR-128-2 serves as a prognostic marker for patients with hepatocellular carcinoma.

Serum miR-128-2 serves as a prognostic marker for patients with hepatocellular carcinoma.

Circulating miRNAs are promising biomarkers for predicting the aggressiveness of hepatocellular carcinoma (HCC). We aimed to identify differentially expressed miRNAs in the serum of HCC patients with different Barcelona Clinic Liver Cancer (BCLC) stage, and to investigate the potential of serum miRN...

Full description

Bibliographic Details
Main Authors: Liping Zhuang, Litao Xu, Peng Wang, Zhiqiang Meng
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2015-01-01
Series:PLoS ONE
Online Access:http://europepmc.org/articles/PMC4313939?pdf=render

Similar Items

Similar Items